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ABSTRACT
CRISPR-Cas9 enables efficient sequence-specific mutagenesis for
creating somatic or germline mutants of model organisms. Key
constraints in vivo remain the expression and delivery of active Cas9-
sgRNA ribonucleoprotein complexes (RNPs) with minimal toxicity,
variable mutagenesis efficiencies depending on targeting sequence,
and high mutation mosaicism. Here, we apply in vitro assembled,
fluorescent Cas9-sgRNA RNPs in solubilizing salt solution to
achieve maximal mutagenesis efficiency in zebrafish embryos.
MiSeq-based sequence analysis of targeted loci in individual
embryos using CrispRVariants, a customized software tool for
mutagenesis quantification and visualization, reveals efficient bi-
allelic mutagenesis that reaches saturation at several tested gene
loci. Such virtually complete mutagenesis exposes loss-of-function
phenotypes for candidate genes in somatic mutant embryos for
subsequent generation of stable germline mutants. We further show
that targeting of non-coding elements in gene regulatory regions
using saturating mutagenesis uncovers functional control elements
in transgenic reporters and endogenous genes in injected embryos.
Our results establish that optimally solubilized, in vitro assembled
fluorescent Cas9-sgRNA RNPs provide a reproducible reagent for
direct and scalable loss-of-function studies and applications beyond
zebrafish experiments that require maximal DNA cutting efficiency
in vivo.
KEY WORDS: CRISPR-Cas9, Zebrafish, Mutagenesis, Genome
editing, RNP, CrispantCal, CrispRVariants
INTRODUCTION
Cas9 nuclease-mediated mutagenesis through non-homologous end
joining (NHEJ) repair enables rapid, site-directed mutagenesis of
candidate genes in zebrafish for somatic as well as stable germline
mutant analysis (Chang et al., 2013; Gagnon et al., 2014; Hwang
et al., 2013; Jao et al., 2013; Shah et al., 2015; Varshney et al.,
2015). Mutagenesis is routinely performed through microinjection
of Cas9-encoding mRNA together with a locus-targeting single-
molecule guide RNA (sgRNA). Upon Cas9 translation, folding, and
formation of stable Cas9-sgRNA complexes in vivo, embryo cells
that accumulate sufficient levels of Cas9-sgRNA complex become
mutated through imperfect NHEJ at the target locus specified by the
sgRNA. This results in a complex genetic mosaic of mutant and
wild-type alleles (Jao et al., 2013). Such incomplete mutagenesis is
desirable for creating germline mutants, as it warrants embryo
survival and yields a spectrum of random alleles to screen for in the
next generation (Hruscha et al., 2013; Varshney et al., 2015). More
recently, in zebrafish and other models several reports showed
increased mutagenesis efficiency upon injection of in vitro
assembled Cas9-sgRNA ribonucleoprotein complexes (RNPs)
that are immediately active upon microinjection and are, variably,
more effective (Gagnon et al., 2014; Kotani et al., 2015; Sung et al.,
2014).
The somatic mutagenesis efficiency of TALENs and Cas9 allows
limited assessment of loss-of-function phenotypes already in the
injected F0 generation, potentially providing a promising reverse-
genetics tool (Bedell et al., 2012; Dahlem et al., 2012; Jao et al.,
2013; Schulte-Merker and Stainier, 2014; Shah et al., 2015).
Somatic and tissue-specific mutagenesis has recently been reported
for Ciona embryos (Stolfi et al., 2014), is possible for assessing
tumorigenesis in mice (Platt et al., 2014), and is achievable using
mosaic transgene injection in zebrafish (Ablain et al., 2015).
Reproducible and significant phenotype penetrance and
expressivity in a given cell type or on a whole-embryo scale
requires a mutagenesis efficiency close to or reaching saturation,
ideally by providing a limited number of alleles. Published efforts
using Cas9-mediated mutagenesis in zebrafish have reported a wide
range of somatic mosaicism upon injection, with variable numbers
of alleles and injection-based mortalities of up to 30% (Auer et al.,
2014a; Chang et al., 2013; Gagnon et al., 2014; Hwang et al., 2013;
Jao et al., 2013; Moreno-Mateos et al., 2015; Shah et al., 2015). The
mutagenesis efficiencies for the different Cas9 applications vary
widely in reported studies, with several groups experiencing 50% or
more of sgRNAs being ineffective for mutagenesis (Moreno-
Mateos et al., 2015; Shah et al., 2015; Sung et al., 2014; Varshney
et al., 2015).
Although various online tools are available to assist in design
and enable limited target efficiency predictions, the variable
mutagenesis efficiency leaves room for optimizing Cas9-mediated
mutagenesis in zebrafish and other model organisms. We reasoned
that highly pure, pre-assembled Cas9-sgRNA RNPs delivered at
optimal conditions into the first cell of the zebrafish embryo would,
if well tolerated, mediate saturating mutagenesis within the first few
cell divisions. This strategy has the distinct advantage that Cas9-
sgRNARNP assembly is not limited by the amount and rate of Cas9
translation, and pre-loaded sgRNAs are possibly protected from
degradation. Here, we describe the in vitro assembly of immediately
active Cas9-sgRNA RNPs in optimized salt solvent to ensure
stability over the course of microinjection. We demonstrate that
fluorescently tagged Cas9 protein to monitor RNP delivery is well
tolerated by zebrafish embryos with minimal to no injectionReceived 6 January 2016; Accepted 12 April 2016
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toxicity, while fluorescence provides an instant readout for efficient
injections and indicates rapid decay of injected RNPs.
We tested mutagenesis efficiency in individual embryos and find
exceedingly high mutagenesis rates that reach 100% for individual
target loci, de facto generating complete somatic mutants by
injection. Despite this exceedingly high efficiency, selective MiSeq
analysis of a range of predicted off-targets for highly effective
sgRNAs reveal no significant off-target mutagenesis consistent
with CRISPR-Cas9 mechanisms, and we observe even a block of
mutagenesis when individual polymorphisms are present at a target
locus. Although we observe that complete somatic mutagenesis
enables loss-of-function readouts in injected embryos, our deep-
sequencing results further call for caution in interpreting somatic
mutagenesis results due to the wide spectrum of alleles generated
with random mutagenesis. Altogether, our approach provides an
optimized mutagenesis tool for in vivo applications that require
maximal mutagenesis efficiency beyond mutagenesis in zebrafish.
RESULTS
Assembly and injection of recombinant, fluorescent Cas9-
sgRNA RNPs
We expressed and purified Streptococcus pyogenes Cas9 protein
fused in-frame with a C-terminal HA epitope tag, nuclear
localization signal sequences, and GFP or mCherry for
fluorescence detection (Cas9-NLS-GFP and Cas9-NLS-mCherry,
respectively) (Fig. 1A, Fig. S1). We further tweaked existing
protocols for T7 or SP6 polymerase-driven in vitro transcription and
purification of sgRNAs (Bassett et al., 2013; Gagnon et al., 2014) to
achieve high purity and concentration using standard laboratory
protocols for simple and scalable, cloning-free sgRNA production
(Fig. S2A). We then combined pure Cas9 protein and sgRNAs and
incubated the mix for 5 min at 37°C to reconstitute active RNPs at
an injection concentration of at least 800 ng/µl Cas9 (831 ng/µl
routinely used in this study). Upon RNP microinjection of a
standard volume of 1 pl into zebrafish embryos at the one-cell stage,
the fluorescence signal from fluorophore-tagged Cas9 is readily
detectable as a homogenous EGFP signal in successfully injected
embryos (Fig. 1B,C) and concentrates to nuclei during subsequent
cell divisions (Fig. 1D,E, Movie 1). RNP fluorescence in the
embryo fades by dilution and possible degradation throughout
development and becomes undetectable above background
fluorescence before 18 h post-fertilization (hpf).
Consistent with reported salt concentrations for effective Cas9
solubility (Anders et al., 2014), we found that increasing the ionic
strength in the reconstitution reaction to at least 300 mM KCl
dramatically improved the solubility of the Cas9-sgRNA RNPs and
limited aggregation in the injection mix and within the embryo cell
(Fig. 1F-I). We found that injections with assembled RNPs at
300 mM KCl were well tolerated by zebrafish embryos: injections
by different experimenters of reconstituted Cas9 RNPs into the cell
proper of single-cell zebrafish embryos led to no significant lethality
or toxicity (n=8; Fig. S2B). We optimized the composition of the
injection mixture such that only three components and water are
required for its preparation: recombinant Cas9 (stored in a protein
purification buffer), in vitro transcribed sgRNA (dissolved in
water), and KCl solution to correct the ionic strength of the mixture
to 300 mM KCl to ensure solubility of the Cas9-sgRNA RNPs. To
aid in the calculation of the correct amounts needed for complex
assembly, we designed CrispantCal, an online tool and
complementary smart-phone app to calculate the correct volumes
needed for optimal reconstitution (Fig. S3 and Materials and
Methods; available at http://lmweber.github.io/CrispantCal/ for
desktop and mobile browsers or installable within R; app
available through Google Play and iTunes AppStore).
Altogether, fluorescent tracking of the Cas9-sgRNA RNPs
provides a simple method to monitor efficient complex solubility
and microinjection-based delivery. The easily detectable GFP or
mCherry fluorescence further allows convenient sorting of
Fig. 1. Microinjection of fluorescent
Cas9 fusion proteins into zebrafish
embryos. (A) Cas9 fusion proteins used in
this study, showing the hemagglutinin tag
(HA), two nuclear localization signals
(NLS), EGFP or mCherry fluorophores, and
a third C-terminal NLS. See Fig. S1 for
protein sequences. (B,C) One-cell stage
zebrafish embryo following microinjection
of reconstituted Cas9-GFP-sgRNA
complex. Brightfield (B) and EGFP
fluorescence (C) reveal precipitated Cas9
complex outside the embryo (arrowheads,
C), and strong EGFP fluorescence in the
embryo cell without contribution to the yolk
cell (asterisk, C). (D,E) Time-course of
injected Cas9-EGFP and nuclear
localization. Note the even distribution in
the developing embryo without yolk
fluorescence (asterisk, D) and minimal
precipitate inclusions (arrowheads, E).
(F-I) Buffering of the Cas9 protein-sgRNA
mix with 300 mM KCl maintains solubility in
the injection mix (F,G) and prevents
precipitation before injection (H,I). Insets
(F,H) show corresponding brightfield
images of fluorescence views.
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efficiently injected embryos for quality control and experimental
reproducibility.
Delivered Cas9-sgRNA complexes efficiently mutate
transgene targets
To test the activity of our assembled Cas9-sgRNA complexes, we
first targeted a single locus in the genome to assess our RNP
efficiency in injected embryos (CRISPR-mediated mutants, or
crispants). We targeted a Tol2-based single-copy transgene that
drives EGFP expression in all embryo cells under the control of
the ubiquitin (ubi) promoter (ubi:EGFP) (Mosimann et al., 2011).
We injected RNPs of a previously described, highly efficient
sgRNA against EGFP (Auer et al., 2014a) into hemizygous
ubi:EGFP embryos (carrying one transgene copy). In parallel, we
co-injected codon-optimized mRNA encoding Cas9-NLS with the
same EGFP sgRNA into siblings from the same clutch. In injected
ubi:EGFP embryos, consistent with previous reports (Auer et al.,
2014a), Cas9 mRNA with EGFP sgRNA caused efficient mosaic
loss of EGFP signal (n=31; Fig. 2A,B,D). By contrast, we
consistently failed to detect significant ubi:EGFP fluorescence
signal in Cas9-sgRNA-injected embryos (n=31; Fig. 2A,C,D),
suggesting complete mutagenesis of the single EGFP target in
these crispants.
This high efficiency is not restricted to ubi:EGFP, as we also
observe complete absence of EGFP expression in other injected
transgenic lines, including myl7:EGFP (Huang et al., 2003) (n=43;
Fig. 2E-J) and wt1b:EGFP (Perner et al., 2007) (n=5; Fig. 2D,K-M)
using our protocol. In addition, we did not detect EGFP protein in
RNP-injected embryos by standard western blot analysis (Fig. 2N).
Complete mutagenesis depends on direct delivery of Cas9-sgRNA
into the embryo cell, as injection into yolk led to EGFP mosaicism
akin to Cas9 mRNA injections (n=5; Fig. S4). These results reveal
that injections of in vitro assembled, optimally salt-solubilizedCas9-
sgRNARNPs into the cytoplasm of the initial embryo cell can result
in consistent and complete loss of reporter signal from targeted
EGFP transgenes, suggesting saturating somatic mutagenesis.
Crispants replicate loss-of-function phenotypes
To assess the efficiency of our solubilized RNP delivery at native,
bi-allelic genomic targets, we next targeted recessive genes that,
upon mutation, cause developmental phenotypes. A gold standard
for targeted mutagenesis in zebrafish is golden (gol; also known as
Fig. 2. Efficient mutagenesis of EGFP reporter transgenes. (A-C) Mutagenesis of the EGFP open reading frame in transgenic embryos that harbor a single
copy of the ubiquitously expressed ubi:EGFP transgene using Cas9 and EGFP sgRNA. (A) 5 dpf uninjected heterozygous ubi:EGFP control sibling and
(B) embryo following injection of Cas9 mRNA with EGFP sgRNA leads to mosaic EGFP expression, as compared with (C) complete loss of EGFP signal upon
Cas9 protein (Cas9p)-sgRNA RNP injection. Insets are brightfield images of fluorescence views. (D) Relative fluorescence quantification of ubi:EGFP and wt1b:
EGFP mutagenesis versus RNP-injected non-transgenic (n.t.) controls. Error bars represent mean with s.e.m. (E-J) EGFP mutagenesis in heterozygous
myl7:EGFP transgenic reporters that express EGFP specifically in heart muscle cells. Left column depicts EGFP fluorescence, right column shows the brightfield
view. (E,F) Control sibling, (G,H) Cas9 mRNA and EGFP sgRNA injection causing mosaic EGFP expression (arrowhead, G), and (I,J) reconstituted Cas9p-
sgRNA complex injection results in complete loss of EGFP signal (asterisk, I). (K-M) EGFP mutagenesis in kidney expressing wt1b:EGFP transgenic reporters.
Brightfield overlay with EGFP fluorescence. (K) Control sibling, (L) mosaic EGFP expression following Cas9 mRNA and EGFP sgRNA injection (arrowhead), and
(M) loss of EGFP following injection of reconstituted Cas9p-sgRNA complex (asterisk). (N) Western blot of EGFP and Tubulin loading control from ubi:EGFP
transgenic embryos (two examples are shown) injected with EGFP sgRNA-containing Cas9-mCherry RNPs and control embryos.
2027
TECHNIQUES AND RESOURCES Development (2016) 143, 2025-2037 doi:10.1242/dev.134809
D
E
V
E
LO
P
M
E
N
T
slc24a5), which encodes a non-essential ion exchanger involved in
skin pigmentation (Lamason et al., 2005). This provides a simple
mutagenesis readout, as gol mutant zebrafish display markedly
lighter melanocyte pigmentation that is readily detectable within
48 hpf (Dahlem et al., 2012; Doyon et al., 2008; Jao et al., 2013).
Targeting gol with Cas9 mRNA reproduced previously published
mosaic phenotypes for TALENs (Dahlem et al., 2012) and Cas9
(Jao et al., 2013) mutagenesis (n=57; Fig. 3A,B), albeit with high
variability and mortality (34.8% of total clutches), in line with
recent reports on delivery of high doses of active Cas9 mRNA and
sgRNA (Shah et al., 2015). When we targeted golwith reconstituted
Cas9-sgRNA complexes, all successfully injected embryos (as
judged by Cas9 fluorescence) showed pigment phenotypes without
other notable morphological defects (n=285; Fig. 3C). As
anticipated from random mosaic mutagenesis, these gol crispants
showed a range of the expected phenotype: we observed complete
gol phenotype expressivity in nearly 80% of injected embryos, with
the remaining 20% showing different degrees of phenotype
mosaicism (Fig. 3A-C,P).
Contrary to morpholinos that maintain gene knockdown only for
a few days post-injection (Bill et al., 2009), crispants carry
mutations in the targeted locus and maintain mutant phenotypes
indefinitely. Since gol is a non-essential gene, we grew up gol
crispants of fully penetrant phenotype to adulthood, throughout
which the animals preserved the typical pigment phenotype of gol
mutants (Lamason et al., 2005) (Fig. 3D,E). Upon incrossing of
adult gol crispants (n=6), their F1 offspring showed complete
penetrance of the recessive gol phenotype in all independently
obtained clutches (Fig. 3F,G), revealing that the Cas9-sgRNA-
targeted gol loci were mutated in the entire germline of all tested
crispants.
The seemingly efficient mutagenesis with optimally solubilized
RNPs also allows assessment of loss-of-function phenotypes of
essential genes. tbx16 is defective in the spadetail (spt) mutant, with
homozygous spt embryos featuring a broadening of the posterior tip
of the tail from failed differentiation of multilineage mesoderm
progenitor cells (Kimmel et al., 1989). Successfully injected
crispants recapitulated the recessive spt phenotype, albeit with
incomplete penetrance and variable expressivity (Fig. 3H,I,P). We
also targeted the lateral plate mesoderm-expressed transcription
factor genes tbx5a and hand2, which when mutated display
compound heart and pectoral fin defects (Garrity et al., 2002;
Yelon et al., 2000). Analogous to the tbx5amutant heartstrings (hst)
and morpholinos (Ahn et al., 2002; Chiavacci et al., 2012; Garrity
et al., 2002), RNP-mediated targeting of tbx5a caused a spectrum of
phenotype expressivity (n=232), including bilateral loss of pectoral
fins and elongated heart tubes in efficiently injected embryos
(Fig. 3J-L,P). The phenotype penetrance for hand2 targeting
(n=308) was less complete but nonetheless replicated the
phenotypes of the known hand2 alleles with variable expressivity
(Fig. 3P) (Yelon et al., 2000). We confirmed that targeting of tbx5a
and hand2 is responsible for the observed phenotypes in trans-
heterozygous mutant F1 embryos derived from F0 incrosses, and
homozygous F2 mutants for selected alleles (Fig. 3M-O). These
hand2 and tbx5a alleles are, to our knowledge, the first newly
derived alleles reported for these key transcription factors.
Altogether, our observations demonstrate that injection of
reconstituted Cas9-sgRNA RNPs into one-cell stage zebrafish
embryos reproduces loss-of-function phenotypes of targeted genes,
albeit with variable phenotype penetrance and expressivity. These
results extend previous reports (Gagnon et al., 2014; Jao et al., 2013;
Shah et al., 2015) for possible loss-of-function phenotype
assessment of candidate genes using Cas9-sRNA injections and
provide a possible framework for phenotype assessment of
candidate genes using minimal background toxicity. Using the
same reagents, injection of submaximal doses or release of Cas9-
sgRNA complexes into the yolk triggers incomplete mutagenesis
suitable for germline mutant generation (Fig. 3M-O, Fig. S4).
Cas9 RNPs injected at the one-cell stage can mutate all
alleles in zebrafish embryos
Unlike highly efficient morpholinos, phenotype penetrance and
expressivity in all injected embryos is variable and incomplete for
several essential genes (Fig. 3P). We next sought to quantify and
characterize the mutagenesis efficiency in individual crispants to
assess whether incomplete phenotype penetrance and expressivity
are a function of incomplete mutagenesis or of other factors.
Reported deep-sequencing analyses of mutagenesis efficiencies
have been performed on pooled embryos with a range of different
methods that allow only limited cross-comparison between
experiments (Gagnon et al., 2014; Shah et al., 2015). We
therefore sought to perform deep-sequencing based on Illumina
MiSeq to determine the mutagenesis efficiency in individual
embryos.
We devised a scalable analysis pipeline in which we selected
individual crispants and PCR-amplified ∼350-500 bp genomic
regions centered on the individual sgRNA recognition sites to
subsequently perform both MiSeq-based deep-sequencing and
limited Sanger sequencing of the PCR products. For Sanger
sequencing, we developed a column-free workflow to rapidly
isolate sequencing-grade DNA from single clones that included
subcloning the PCR fragment and performing a colony PCR assay
(see Materials and Methods for details and extended protocols).
To establish standardized analysis and interpretation of the
mutagenesis spectrum, we devised CrispRVariants, a flexible and
scalable R-based software package. CrispRVariants is reproducible,
scalable to large data sets, and transparent and flexible about
which reads are included in efficiency calculations (Lindsay et al.,
2015 preprint). CrispRVariants counts every variant allele and
localizes variants with respect to the cut site, enabling simple
comparison of the full mutation spectrum between guides and
exclusion of pre-existing genomic variants, e.g. in a non-
homozygous experimental population. As graphical output, the
software provides standardized summaries of individual crispants or
any other input sequences for phenotype versus mutagenesis,
including quality assessment plus automated illustration of resulting
mutant variants and mutagenesis quantification using panel plots to
illustrate allele sequences per embryo (Fig. 4A).
Based on our deep-sequencing data for 48 loci (25 on-targets, one
control, and a total of 22 predicted off-targets for six on-targets)
in up to six individual embryos each (see Materials and Methods
for details), our RNP-based mutagenesis approach results in an
exceedingly high on-target efficiency upon optimized RNP
injection, with selected crispants featuring complete mutagenesis
at individual loci (Fig. 4A,B, Table S1, and individual panel plots of
MiSeq-analyzed targets in Fig. S5A-O). We found an average
mutagenesis rate of 91.26% (median 94.06%, average read count
above 32,000 per locus) for the analyzed targets. Consistent with
previous reports of Cas9 use in zebrafish (Gagnon et al., 2014;
Hruscha et al., 2013; Hwang et al., 2013; Jao et al., 2013), the
majority of induced (and PCR-recovered) alleles consist of small
deletions and insertions (indels), with fewer larger indels (Fig. 4A,
Fig. S5A-O). Several analyzed loci, including gol, atg7, camk2g1
and xirp1, feature at least one predominant recurring mutation in
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Fig. 3. Recapitulation of mutant and morpholino phenotypes in crispants. (A-G) Mutagenesis of golden (gol). (A) wild-type control. (B,C) Targeting with
Cas9 mRNA causes mosaic pigment cell phenotypes (B), while solubilized RNP injections can result in zebrafish embryos devoid of wild-type melanocytes (C)
that completely mimic the gol mutant phenotype. (D-G) Whereas control siblings develop characteristic pigment patterns as adults (D), fully penetrant gol
crispants maintain their mutant phenotype to adulthood (E) and completely transmit mutant gol alleles to the F1 generation when incrossed with other gol
crispants (F,G). Adult zebrafish are shown as composite images. F1 phenotypes were assessed from three crispant incrosses resulting in normally sized (75-100)
to big (250-300) clutches. (H,I) Crispants for tbx16 can form the characteristic spadetail (spt) phenotype of tbx16 mutants (arrowhead in I, see also Fig. S5K,L).
(J-L) Crispants for tbx5a recapitulate the pectoral fin and heart phenotypes of tbx5amutants andmorphants, showing a range of phenotype expressivity including
cardiac edema (asterisk, K) and unilateral pectoral fin defects (arrowhead, K), or complete heart tube stretching (asterisk, L) and pectoral fin loss (arrowheads, L).
(M-O) Phenotype/genotype correlation of tbx5a and hand2 F2 embryos featuring two different alleles. Red box, target sequence; PAM is in yellow. (P) Phenotype
penetrance and expressivity for tested crispants. All embryos summarized in the graph were quality controlled for injection by fluorescence microscopy for the
tagged RNP directly after injection; non-fluorescent embryos were discarded; dead embryos were counted at 1 dpf and included unfertilized embryos.
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Fig. 4. See next page for legend.
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independently targeted embryos (Fig. 4A,D, Fig. S5A,C,O),
suggesting locus-dependent preferential NHEJ repair following
Cas9-mediated double-strand break induction. In contrast to
completely mutant crispants, we do recover unmutated alleles in
individual crispants that show incomplete phenotype penetrance
and variable expressivity for the expected phenotype (Fig. 3P), in
particular for tbx16 (spt) (Fig. 4B,D, Table S1, Fig. S5K,L). Of
note, CrispRVariants analysis of the EGFP open reading frame
targeted with RNPs and Cas9 mRNA in ubi:EGFP transgenes
(Fig. 2) also revealed complete mutagenesis for the sequenced
RNP-injected embryos (Fig. S5W).
The average allele variant number per targeted locus ranged from
3.67 to 16.83 different alleles per embryo (Table S1). Assuming that
mutagenesis of a given locus continues to generate independent
variants as long as the sgRNA template can guide Cas9 to the locus
and the locus can be cleaved by Cas9, these results suggest that
mutagenesis saturation is reached at different time points across
individual loci. Every target we tested for this study harbored an
abundance of alleles, including gria3a, which was previously
reported as a difficult target for Cas9 mRNA and Cas9 protein
mutagenesis (Gagnon et al., 2014) (Fig. 4B-D, Fig. S5F,T, Table S1,
Fig. S6A,B). Consistent with immediate activity of optimally
reconstituted RNPs, we already detected mutant alleles in individual
crispants analyzed at germ ring and 32-cell stage (gol and pcdh12,
respectively), as compared with Cas9 mRNA injections, which
showed few if any retrievable mutations in gol by the 32-cell stage
(Fig. S7).
MiSeq or similar exhaustive deep-sequencing analysis of
individual targets is impractical for mutagenesis assessment of
single targets during routine experiments. We therefore also
performed analysis of the same crispants using Sanger sequencing
of a limited number of individual clones from PCR products, as
routinely reported to assess mutagenesis efficiency (Auer et al.,
2014a; Jao et al., 2013; Stolfi et al., 2014; Varshney et al., 2015).
For analyzed targets with good sequence coverage (n=12 or more),
our analysis revealed that limited Sanger sequencing data strongly
correlate with our MiSeq data: for all analyzed loci, Sanger
sequencing of subcloned PCR fragments (1) reliably established a
mutagenesis efficiency estimate (Fig. 4B) and (2) recovered the
most frequent alleles retrieved by deep-sequencing (Fig. S5A).
Alleles frequently recovered by MiSeq or Sanger sequencing of F0
embryos targeted for gol, tbx16, tbx5, hand2 and xirp1 also transmit
through the germline (Fig. 3N,O, Fig. S8), in line with previous
reports on a larger cohort of target loci mutated with Cas9 mRNA
(Varshney et al., 2015).
The random nature of mutagenesis resulting from efficient NHEJ
can result in in-frame lesions (indels with base pair multiples of
three) that are predicted to maintain open reading frame integrity.
We frequently recovered such in-frame variants in independently
targeted genes (Fig. 4A, Fig. S5). This observation reveals that
randomly generated in-frame alleles, which potentially maintain
open reading frame integrity (yet nonetheless might impact amino
acid residues important for protein function), are a major
uncontrolled variable in the use of crispants induced by any
method to directly assess loss-of-function phenotypes, both on a
whole-embryo (Shah et al., 2015; this study) and on a tissue-specific
(Ablain et al., 2015; Stolfi et al., 2014) scale.
High sequence fidelity of Cas9-mediated mutagenesis in
zebrafish
We also analyzed the possibility of off-target effects. Previous
accounts reported remarkably low off-target mutagenesis for
analyzed loci (Shah et al., 2015; Varshney et al., 2015). We
investigated 22 loci for off-targets [based on CasOT score (Xiao
et al., 2014) and proximity to genes], of which we excluded one off-
target due to a strain-specific deletion (camk2g1_off2) and one due
to a possible sequencing error from a homopolymer run (xirp1_off2)
(Lindsay et al., 2015 preprint). We found no single predicted off-
target locus to be mutant above the threshold of the MiSeq error rate
(Table S1). Although our analysis is limited to the predicted off-
targets that we probed, we also routinely found cases where even
single SNPs in target sequences completely abolished the
mutagenesis efficiency: our pitx2ab target sequence features a
SNP adjacent to the Cas9 cut site, resulting in no cutting (Fig. S5J),
while the tbx16 sgRNA ccC harbors two SNPs in the WIK strain
that completely resisted mutagenesis (Fig. S9). These observations,
together with previous reports, differ from findings in other model
systems in which higher degrees of sequence divergence are
tolerated by Cas9 RNP complexes. We interpret these data as a strict
sequence dependence of Cas9-mediated mutagenesis using the
Fig. 4. Mutation spectrum in individual F0 embryos as analyzed by
CrispRVariants. (A) Panel plot output of mutagenesis in gol crispants as
created by CrispRVariants analysis of MiSeq data from individual embryos.
The gene schematic at the top shows the location of the sgRNA in red with
respect to all overlapping Ensembl transcripts on the reference strand. The left
panel shows the pairwise alignment of each variant to the reference genome,
oriented so the PAM is 3′ of the alignment. The 20 bp sgRNA and 3 bp PAM
sequences are indicated by boxes on the reference sequence, and the cut site
is indicated by a vertical line. Deletions are indicated by ‘-’ and insertions by
symbols above the corresponding alignments, with the inserted sequence(s)
shown underneath the plot. Variants are grouped based on the position of
insertions and deletions. The consensus sequence is shown for all sequences
sharing a variant, using IUPAC ambiguity codes for sequence differences. The
variant locations are numbered by their most upstream basewith respect to the
cut site, i.e. a 6 bp deletion from 7 to 2 bases upstream of the cut site would be
labeled ‘−7:6D’. The right panel shows the frequency of the variants in each
embryo. Colors correspond to variant frequencies. The header shows the total
number of MiSeq-derived sequences in each embryo. (B) Mutagenesis
reaches saturation (100%) for several targets in individual embryos. Plot
depicts the average mutagenesis efficiency (frequency of variants containing
indels) in individual embryos for loci analyzed with both Miseq and Sanger
sequencing of PCR clones (seeMaterials andMethods for details). The overall
mutagenesis efficiency determined by both methods correlates with a Pearson
product-moment correlation coefficient of r=0.926. (C) Optimized RNP
mutagenesis occurs early during development. Cumulative proportion of all
detected indel variants in single embryos accounted for by the top 100 indel
variant alleles for camk2g1, ordered from most to least frequent, for crispants
generated in this study and RNP-mediated mutagenesis in Gagnon et al.
(2014). Each line shows the results for a single embryo (n=6 embryos; n=12
embryos for Gagnon et al.). Theoretically, the proportion of a variant allele
reflects the cell stage at which the variant occurs. A y-intercept of 0.5 would
represent a variant that occurred at the single-cell stage; in practice, two
separate mutation events could generate the same allele or the PCR
amplification might not preserve the allele proportions. Higher y-intercept
indicates earlier mutation occurrence; the maximum y-value is the mutation
efficiency when chimeric read alignments are excluded. See Fig. S6 for
additional examples. (D) The frequency and recurrence of mutant alleles. Each
point shows the frequency of a mutant allele among the variant reads for a
single sample. Points are colored by the number of samples in which the allele
occurred. Repeated observations of the same allele are connected by lines,
revealing an abundance of high-frequency reoccurring alleles for most
targeted regions. For example, one mutant allele recurred in all six samples for
atg7 and accounted for 20-70% of the total mutant sequences. Six samples
were sequenced for each guide except beclin1, spt_ccA (four embryos) and
spt_ccC (two embryos). Alleles of at least 1% frequency among the sequenced
reads for a guide and of at least 10% frequency among the variant alleles are
shown. Off-targets marked by asterisks feature sequencing errors or genetic
variation (see text for details). See also panel plots in Fig. S5 for individual
sequence details.
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current methods applied in zebrafish, possibly owing to the limited
activity window of injected Cas9 mRNA or RNP complexes during
the rapid embryonic development.
Functional assessment of gene regulatory elements
Establishing the developmental contribution of non-coding
functional elements in the genome, such as transcription factor
binding sites and enhancers, remains experimentally challenging.
The flexibility of sgRNA design and efficient mutagenesis using
our RNP approach prompted us to assess the feasibility of mutating
genomic sequences outside of open reading frames to assess their
developmental contribution by direct injection.
The minimal regulatory element of the zebrafish myl7 gene
(formerly cmlc2) harbors several predicted transcription factor
binding sites that have been implicated in driving myl7 expression
based on transgenic reporter experiments (Huang et al., 2003)
(Fig. 5A). We individually targeted the putative GATA factor
binding site (−139 to−131 bp upstream from the transcription start)
and the MZF motif [−96 to −89 bp (Huang et al., 2003)] of myl7
with dedicated sgRNAs in embryos carrying a single copy of a
transgenic myl7:EGFP reporter in addition to the endogenous myl7
loci (Fig. 5B-D, Fig. S10A,B). At 36 hpf, myl7:EGFP reporter
fluorescence was severely diminished or abolished in crispants with
a targeted GATA site (Fig. 5E,F), while MZF site crispants had
strongly decreased reporter activity (Fig. 5G,H). Additionally,
embryos with impaired reporter expression developed mild cardiac
edema and slowed heart beat (Fig. 5E,G), reminiscent of the
reported myl7 morpholino and mutant phenotype (Huang et al.,
2003; Stainier et al., 1996). Targeting the intermittent genomic
region between the GATA and the MZF site did not interfere with
myl7:GFP reporter expression despite efficient mutagenesis
(Fig. 5I,J, Fig. S10C), ruling out a non-specific effect of binding
site mutagenesis on minimal promoter elements or the EGFP
transcriptional unit.
Since the targeting sgRNAs recognize both the myl7:EGFP
reporter insertion and the two native myl7 loci, we assessed
endogenous myl7 expression by mRNA in situ hybridization at
36 hpf (Fig. 5K-N): GATA factor site-targeted crispants invariantly
showed mosaic or completely abolished myl7 expression (77% and
23%, respectively, n=98; Fig. 5L,M), while MZF site-targeted
animals showed a marked decrease of endogenous myl7 expression
(89%, n=19; Fig. 5N). Germline transmission of myl7:EGFP
reporter transgenes with the mutant GATA binding site confirmed
the crispant findings (Fig. 5P-T). These data highlight the potential
of crispants to uncover native and reporter-based non-coding
regulatory sequences in the zebrafish genome.
DISCUSSION
Genome editing using zinc fingers, TALENs, and now CRISPR-
Cas9 has significantly facilitated genome engineering in model
organisms. Nonetheless, assessment of loss-of-function phenotypes
beyond the contested temporary morpholino-mediated knockdown
(Kok et al., 2015) requires the generation of stable mutant strains,
which puts a heavy burden on the capacity and costs of animal
facilities. Several recent reports suggested the feasibility of direct
phenotype readouts from somatic whole-embryo or tissue-specific
mutagenesis (Ablain et al., 2015; Bedell et al., 2012; Dahlem et al.,
2012; Jao et al., 2013; Platt et al., 2014; Schulte-Merker and
Stainier, 2014; Shah et al., 2015; Stolfi et al., 2014). Such F0-based
phenotype assessment depends on high mutagenesis efficiency,
ideally complete saturation with limited loss-of-function allele
mosaicism. Here, we extend and refine previous reports of in vivo
mutagenesis and direct phenotype readout upon injection of locus-
specific endonucleases in zebrafish by injecting highly pure, pre-
assembled, and optimally solubilized Cas9-sgRNA RNPs. Using
detailed protocols and dedicated software tools to streamline
injection mixes (CrispantCal) and, in particular, data analysis
(CrispRVariants) (Lindsay et al., 2015 preprint), our approach
provides exceedingly high mutagenesis rates that reach saturation in
individual embryos for particular targets. To our knowledge, this is
the first report of saturating mutagenesis of individual candidate loci
using the CRISPR-Cas9 system in a model organism.
Published reports of CRISPR-Cas9 deployment in zebrafish vary
widely in terms of the reported concentrations for sgRNA and Cas9
mRNA or protein, mutagenesis efficiency, and the assessment of
resulting mutant alleles (Auer et al., 2014a,b; Chang et al., 2013;
Gagnon et al., 2014; Hruscha et al., 2013; Hwang et al., 2013; Irion
et al., 2014; Jao et al., 2013; Kimura et al., 2014; Moreno-Mateos
et al., 2015; Sung et al., 2014). In our hands, some of this stems from
experimental variability in the delicate preparation and handling of
in vitro transcribed RNA components and in the mechanical process
of individual microinjections. Our results highlight that validated
working stocks of recombinant Cas9 protein provide a more
consistent reagent for CRISPR-Cas9 mutagenesis than long, in vitro
transcribed and capped Cas9 mRNA. Freshly reconstituted and
buffered Cas9-sgRNA RNPs can be appropriately titrated for
traditional germline mutagenesis or somatic mutagenesis in
crispants. Cas9 fusions with GFP or mCherry facilitate immediate
quality control of the injection to minimize experimenter-influenced
variability. Of note, appropriate adjustment of ionic strength with
300 mM KCl to solubilize and stabilize the reconstituted injection
mixes markedly improves the mutagenesis efficiency compared
with previous Cas9 protein-based approaches (Chang et al., 2013;
Gagnon et al., 2014) (Fig. 4, Figs S5 and S6). Such optimized
efficiency is likely to be of benefit to applications that depend on
saturating DNA cutting, such as homologous recombination or
insertion of short exogenous DNA sequences. Our solubilized
RNPs are also likely to be directly transferable to other model
organisms beyond zebrafish that allow injection-based RNP
delivery.
Although we cannot exclude the possibility, several observations
suggest that off-target mutagenesis of our solubilized Cas9 RNPs in
injected zebrafish embryos is minimal: first, SNPs at a sgRNA-
targeted locus inhibit Cas9 function (Fig. S9); second, germline-
transmitted genomes from highly mutagenized crispants maintain
highly specific phenotypes (Fig. 3F,G,M-O, Fig. 5P-S, Fig. S8); and
third, although limited to CasOT-predicted key off-targets, we
cannot detect any significant off-target mutagenesis, consistent with
previous reports and our re-analysis of their data (Gagnon et al.,
2014; Lindsay et al., 2015 preprint; Shah et al., 2015). Besides the
native sequence fidelity of the CRISPR-Cas9 system, our
observations of injected fluorescent Cas9 RNPs suggest a
relatively short activity window of only a few hours post-injection
(Fig. 4C, Fig. S6B-D). The high numbers of individually injected
embryos combined with independent experiments using at least two
different sgRNAs per targeted gene would possibly further mitigate
off-target effects. Our work also underlines once more that the high
fidelity required for complementary sgRNA sequences warrants
careful assessment for polymorphisms in the target region; use of
sequence-characterized zebrafish strains such as NHGRI-1 (LaFave
et al., 2014) will greatly facilitate extended crispant experiments.
Genes or regulatory sequences with promising crispant
phenotypes can further be targeted using subsaturating complex
concentrations or yolk injections to generate stable mutant alleles
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that can be phenotypically assessed in the F1 using crispant
incrosses (Varshney et al., 2015). Despite the high mutagenesis
efficiency, a major caveat for phenotype analysis using F0 crispants
as phenotype readout remains the occurrence of unpredictable
mosaic allele combinations. Previous studies hypothesized a high
somatic allele count (thousands) following Cas9-mediated
mutagenesis in somatic tissue (Jao et al., 2013). We find
significantly fewer alleles in crispants for selective genes than
anticipated (Fig. 4D, Table S1, Figs S5-S7, S10), suggesting that, in
the optimal case, mutagenesis by our solubilized RNPs is saturating
Fig. 5. Crispant analysis of transcription factor binding sites upstream ofmyl7. (A) The zebrafishmyl7 locus encoding cardiac myosin light chain 7, with an
enlarged depiction of the upstream regulatory region and putative GATA and MZF transcription factor binding sites. (B) Panel plot depicting Cas9-mediated
mutagenesis of the GATA site region in individual representative crispants for the endogenous myl7 locus and the single-copy myl7:EGFP transgene.
(C-J) Anterior lateral views at 36 hpf of heterozygous transgenics for myl7:EGFP targeted with sgRNAs recognizing the GATA or MZF binding site or the
interspersed region between the two sites (INTER) inmyl7with solubilized RNPs. (C,D) Control sibling with EGFPexpression in the heart tube. (E,F) Reduction or
loss of EGFP upon targeting of the GATA site with sgRNA[GATA], (G,H) the MZF site using sgRNA[MZF] or (I,J) the interspersed sequence with sgRNA[INTER].
Arrowheads indicate cardiac edema (E,G); asterisks indicate impaired EGFP signal (F,H). (K-N) mRNA in situ hybridization (ISH) for endogenous myl7
expression at 36 hpf in examples of control siblings (K), GATA site crispants (L,M) and MZF site crispants (N). (K) A, atrium; V, ventricle. Arrowheads indicate
decreased myl7 expression (L,N); asterisk indicates complete loss of ISH signal (M). (O) Phenotype penetrance and expressivity of myl7 ISH signal in
transcription factor site crispants. (P-S) Germline transmission of GATA site mutations. (P,Q) Control myl7:EGFP sibling. (R,S) GATA site germline mutant from
crispant incross, featuring cardiac edema (arrowhead, R) and impaired EGFP expression (asterisk, S). (T) Allele sequences of endogenous and hemizygous
transgene locus in an F1 embryo, featuring lesions in the predicted GATA site.
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after few initial cell divisions. We do consistently recover in-frame
indels, which potentially create hypomorphic or even functionally
unaffected alleles (Gagnon et al., 2014) (Fig. 4A, Fig. S5).
Appropriate design of the sgRNA targeting region in a given
sequence might mitigate this issue. Nonetheless, the overall
robustness of the DNA triplet code, translation initiation and
splicing warrant close examination of every targeted locus. Our
observations emphasize the importance of designing sgRNAs
against gene regions that encode conserved domains or functional
entities in the final protein product or RNA, and to assess crispant
phenotypes with at least two distinct sgRNAs. This approach is
potentially augmented by using design tools to pick highly efficient
sgRNAs (Moreno-Mateos et al., 2015). For example, our
mutagenesis of gol predominantly results in a 3 bp deletion that
invariantly causes complete loss of pigmentation in crispants and
mutant F1 zebrafish (Fig. 4A). This 3 bp deletion allele removes
Val120 at the edge of the third predicted transmembrane helix of
SLC24A5, suggesting functional impairment of protein structure as
a result (Lamason et al., 2005). By contrast, our mutagenesis of
tbx16 caused in-frame alleles that have no phenotypic consequence
in crispants and the F1 (Fig. S5K,L, Fig. S9). Mutagenesis of
essential genes can potentially trigger strong selection against cells
with detrimental alleles and the enrichment for cells with mutant
alleles that retain function, such as possible downstream start
codons when targeting the initial ATG or cryptic splicing upon
targeting an exon-intron boundary. sgRNA prediction algorithms
that assist in targeting functional features of the resulting proteins in
the genomic coding sequence would potentially improve mutant
phenotype penetrance and expressivity in the injected F0. Further,
positive selection for deletion alleles that maintain protein function
represents a potent proxy to uncover functional domains in protein-
coding genes using germline mutants. Nonetheless, our
observations, despite resulting from exceedingly efficient
mutagenesis, call for careful interpretation of somatic mutagenesis
analysis in F0 animals performed by somatic or inducible Cas9
expression in zebrafish and other in vivomodels (Ablain et al., 2015;
Stolfi et al., 2014; Yin et al., 2015). Conditional alleles made with
floxed exons that will allow Cre-mediated tissue-specific
inactivation are now in reach for the zebrafish field and will help
in addressing this caveat.
The targeting of non-coding regulatory elements potentially
requires less stringent sgRNA design, yet remains challenging
owing to the relatively small size of potentially functional chromatin
regions, such as transcription factor binding sites. Recent studies
have successfully employed systematic enhancer targeting in cell
culture systems (Canver et al., 2015; Korkmaz et al., 2016). Our
efficient RNP-mediated mutagenesis approach outlined here now
paves the way to extend systematic enhancer analysis to in vivo
model systems. Although labor- and animal number-intensive, the
generation of germline mutant allelic series of deletions/insertions
spanning a particular transcription factor binding site or whole
enhancer will allow for precise assessment of functional non-coding
elements. Overall, our results suggest that crispant-based systematic
functional assessment of non-coding genome elements is highly
efficient in zebrafish (Fig. 5) and possibly represents a high-
throughput platform to reveal the developmental contribution of
regulatory elements.
MATERIALS AND METHODS
Zebrafish husbandry and experimentation
Zebrafish (Danio rerio) were maintained, collected and staged as described
(Kimmel et al., 1995). Embryos were raised at 28.5°C if not stated otherwise.
Injections into phenotypically wild-type embryos were performed using
WIK, Tü, and mixed WIK/Tü strains, with prior sequence verification of
the target locus. Transgenic lines used in this study are ubiquitous for
EGFP: ubi:Switch [Tg(–3.5ubb:LOXP-EGFP-LOXP-mCherry), cz1701Tg]
(Mosimann et al., 2011); reporter for myl7:EGFP [Tg(–3.5ubb:Cre-ERT2,
myl7:EGFP), cz1702Tg] (Mosimann et al., 2011); and Tg(wt1b:EGFP)
(Perner et al., 2007). Detection of endogenous myl7 expression by mRNA
in situ hybridization was performed as described (Thisse and Thisse, 2008);
all embryos were processed in parallel with identical staining times.
Brightfield, in situ hybridization and basic fluorescence imaging were
performed using a Leica M205FAwith a DFC450 C camera; selective plane
illumination microscopy (SPIM) was performed using a Zeiss Z.1. Images
were processed using Leica LAS, ImageJ (NIH), Photoshop CS6 (Adobe)
and PaintShop Pro 7 (Corel) software; whole adult captures are composites
stitched using Photoshop CS6.
Cas9 protein production and storage
The Cas9-NLS-GFP and Cas9-NLS-mCherry proteins are composed of the
polypeptide sequence of Streptococcus pyogenes Cas9 fused in-frame with
a C-terminal HA epitope tag, a bipartite nuclear localization signal (NLS)
sequence, a fluorescent protein (GFP or mCherry) polypeptide and an
additional monopartite NLS at the very C-terminus (Fig. S1). The DNA
sequence encoding the Cas9-NLS-GFP polypeptide was PCR amplified
from plasmid pMJ920 (Jinek et al., 2013) (Addgene) using the following
primers (5′-3′): forward, TACTTCCAATCCAATGCCACCATGGACAA-
GAAGTACAGCATCGG; reverse, TTATCCACTTCCAATGTTATTACT-
CAACTTTTCGTTTTTTCTTAGGTGACCCCTTGTACAGCTCGTCCA-
TGCCG. The PCR product was inserted into expression plasmid 2C-T (gift
from S. Gradia, UC Berkeley Macro Lab; information available from
Addgene) using ligation-independent cloning (LIC). The resulting
expression plasmid (pMJ922, available from Addgene) produces Cas9-
NLS-GFP as a fusion with an N-terminal hexahistidine-maltose binding
protein (His6-MBP) affinity tag that is removed by cleavage with Tobacco
etch virus (TEC) protease during purification. The protein was expressed in
E. coli Rosetta 2 cells as described (Anders et al., 2014). Cells were
resuspended in 20 mM Tris, 250 mM NaCl, 5 mM imidazole pH 8.0 and
lysed using a pressure homogenizer (Avestin). Cell lysate was clarified by
centrifugation at 40,000 g for 45 min and applied to a 10 ml HIS-Select Ni
column (Sigma-Aldrich). The column was washed extensively with 20 mM
Tris, 250 mM NaCl, 10 mM imidazole pH 8.0 and eluted with 20 mM Tris,
250 mM NaCl, 250 mM imidazole pH 8.0. Eluted protein was dialyzed
against 20 mM HEPES, 100 mM KCl, 10% glycerol, 1 mM dithiothreitol
(DTT), 1 mM EDTA pH 7.5 overnight at 4°C in the presence of TEV
protease to remove the His6-MBP affinity tag. Cleaved protein was bound to
a HiTrap SP FF cation exchange column (GE Healthcare) and eluted with a
linear gradient of 0.1-1.0 M KCl. In a final polishing step, CAS-NLS-GFP
was purified on a Superdex 200 16/600 size exclusion column (GE
Healthcare), eluting in 20 mM HEPES, 100 mM KCl pH 7.5. The protein
was concentrated to 15 mg/ml using a 50,000 MWCO centrifugal
concentrator (Amicon) and 50 µl aliquots were flash-frozen in liquid
nitrogen and stored at−80°C.We further made one-time use stocks of 2-3 µl
in PCR tubes also stored at −80°C.
sgRNA production
Oligos were obtained from Life Technologies as standard primers except
where otherwise noted. sgRNA templates were generated as described
(Bassett et al., 2013; Gagnon et al., 2014; Hwang et al., 2013), either using
cloning into pDR274 (Hwang et al., 2013) followed by PCR amplification
of the sgRNA template with (5′-3′) forward primer GCACCGCTAGCT-
AATACG and reverse primer AAAAGCACCGACTCGGTGC, or oligo-
based (Bassett et al., 2013; Gagnon et al., 2014) using the sgRNA forward
primer for T7 templates GAAATTAATACGACTCACTATA-N20-GTTT-
TAGAGCTAGAAATAGC or SP6 GAAATATTTAGGTGACACTATA-
N20-GTTTTAGAGCTAGAAATAGC (with N20 indicating the target site)
and the invariant reverse primer AAAAGCACCGACTCGGTGCCACTT-
TTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCT-
AGCTCTAAAAC (PAGE-purified, Life Technologies). Our sgRNA
nomenclature uses the abbreviation cc (crispr cutter) followed by an
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indexing letter (i.e. ccA, ccB, etc.) to distinguish sgRNAs targeting the
same gene. Primer extension was performed using Phusion polymerase
(NEB) followed by QIAquick purification (Qiagen) with elution in DEPC-
treated water. In vitro transcription of sgRNAs based on the templates
above was performed using the MAXIscript T7 or SP6 Kit (Ambion) with
the reaction run at 37°C overnight, followed by ammonium acetate
precipitation as per the manufacturer’s protocol and as described
previously (Bassett et al., 2013; Gagnon et al., 2014). We found that
adding NTPs at 100 mM instead of the 10 mM recommended in the
manufacturer’s protocol greatly increases sgRNA yield. Precipitated
sgRNA pellets were visualized with GlycoBlue (Life Technologies).
Before use, all sgRNAs were quality controlled on denaturing 2.5%MOPS
gels. Oligos used in this study are listed in Table S2.
Complex assembly, salt stabilization and microinjection
Injection mixes contained, as standard, 831 ng/µl Cas9-EGFP or Cas9-
mCherry, with purified sgRNA added. We recommend 800-900 ng/µl Cas9
per injection mix as a starting amount. 900 ng Cas9-EGFP (191.2 kDa)
corresponds to 4.7×10−9 mol active sgRNA-Cas9 complexes, which were
formed by mixing sgRNA and Cas9 protein buffered with KCl (2 M stock
added for final concentration of 300 mM) and incubation for 5 min at 37°C.
Injection mixes were then used directly without further storage.
To facilitate the setup of injection mixes, we developed the web-based
and smart-phone tool CrispantCal to calculate injection mix volumes
corresponding to an optimal ratio of gRNA to Cas9 protein molecules. The
CrispantCal software allows the user to enter molecular properties and
concentrations of gRNA and Cas9 protein samples, volume of Cas9
solution, and desired total volume. Optionally, desired final concentration of
Cas9 can be specified instead of total volume. Volumes for an optimal
injection mix ratio are then calculated and displayed. Additional volume of
KCl diluent required for optimal reaction efficiency can also be calculated.
This tool calculates volumes corresponding to a perfect 1:1 mix ratio of
gRNA to Cas9 molecules in an injection. The ‘KCl diluent’ option
calculates the additional volume of KCl diluent required to increase the
concentration in the injection mix to a desired final value; recommended is
300 mM KCl. Of note, CrispantCal also provides guidelines for generating
RNP injection mixes with two sgRNAs to generate mutants with larger
targeted deletions. See the main text for a discussion on this approach.
The web-based CrispantCal tool was developed using the Shiny
web application framework (RStudio, http://shiny.rstudio.com/) for the
statistical programming language R. The tool is accessible online together
with further details on usage and calculations at http://lmweber.github.io/
CrispantCal/antCal/, or within R using the commands install.packages
("shiny"); shiny::runGitHub("lmweber/CrispantCal"). The smart-phone
app for Android and iOS platforms was written in Java and Objective-C,
respectively. After user input of the concentration of the corresponding Cas9
protein version, the KCl concentration in the Cas9 protein stock, and the
sgRNA stock concentration, the tool calculates the amounts of water, protein
stock and sgRNA, which are displayed as injection mix. The code for these
applications can be found at https://bitbucket.org/raulcatena/crispantcal
and https://bitbucket.org/raulcatena/crispantcal-android, and the compiled
applications are freely available from Google Play Store (Android) and
iTunes AppStore (iOS).
Microinjection
Microinjections were performed using MPPI-3 pressure injector units (ASI)
with needles pulled from filamented capillaries (WPI) on a Sutter
Instrument P-97 and guided with Narishige M-152 micro-manipulators.
Injection droplets were calibrated to ∼100-125 µm at the start of injection,
resulting in 0.5-1.5 nl injection mix delivered into the embryo cell, unless
noted otherwise.
Fluorescence quantification
The quantification of GFP signal reduction upon sgRNA targeting was
performed on images taken with identical settings on a Leica M205FAwith
a DFC450 C camera by RGB analysis (additive red-green-blue color space)
gated around the embryo outline in ImageJ 1.46r software. Intensity values
for each individual gate were statistically analyzed in GraphPad Prism 5.
Immunoblotting
mCherry-tagged RNPs were injected into one-cell stage ubi:EGFP embryos
and injections were quality controlled for mCherry fluorescence. At 48 hpf,
protein was isolated from 30 uninjected control embryos and 30 RNP-
injected embryos and processed as SDS samples on MINI-Protean TGX
gels (4-20%; BioRad) with running buffer [25 mM Tris, 192 mM glycine,
0.01% (w/v) SDS; if necessary, adjust the pH to 8.3]. Blot transfer was
performed using Trans-Blot Turbo nitrocellulose membrane (BioRad),
followed by blocking (5% milk) and washing in TBST (150 mM NaCl,
50 mM Tris pH 7.5, 0.1% Tween 20). To probe the blot, anti-GFP
(#11814460001, Roche; 1:1000) and mouse anti-Tubulin (sc-32293, Santa
Cruz; 1:2000) antibodies were used. HRP-conjugated goat anti-mouse (115-
035-003, Jackson Laboratories; 1:5000) secondary antibody was used. The
blot was developed using Western Bright ECL solution (Advansta) and
detected on an ImageQuant LAS 4000 imager (GE Healthcare Life
Sciences).
Molecular analysis
To isolate genomic DNA from crispants or F1 mutants, single embryos of
appropriate stages were incubated in 50 μl alkaline lysis buffer (25 mM
NaOH, 0.2 mM disodium EDTA, pH 12.0) at 95°C for 30 min (Mosimann
et al., 2013). The samples were then quenched on ice and neutralized with
5 µl of 1 M Tris-HCl pH 8.0). Debris was removed by centrifugation at 5000
g for 5 min and transferring the supernatant to fresh tubes. The supernatant
was kept at 4°C for short-term or at −20°C for long-term storage.
sgRNA target sites were amplified with flanking primers designed to
amplify 350-500 bp of the individual genes (see Table S2 for sequences)
using GoTaq G2 Green Master Mix (Promega). Reactions were performed
in a total volume of 25 μl according to the manufacturer’s instructions, using
1 μl template DNA. Annealing temperature and elongation time were
adjusted to individual primers and product length according to
manufacturer’s instructions. Primers used for allele analysis are listed in
Table S2.
PCR products were purified with the QIAquick Gel Extraction Kit
(Qiagen) and subcloned using the pGEM T-Easy system (Promega).
Successful ligation was confirmed with the ready-to-use X-gal solution
system (ThermoScientific) with readout as white colonies. Colony PCRs
were performed using T7 and SP6 primers using GoTaq G2 Green reaction
mix. We refined three protocols for colony PCR and subsequent purification
for sequencing.
For procedure 1, white clones were suspended in 20 μl LB medium.
Successful clones were confirmed in a 10 μl GoTaq G2Green reaction using
0.5 μl colony suspension as template. Successful clones were expanded
overnight in 2 ml LB medium (Amp 1:1000) and plasmids were purified
with the QIAprep Spin MiniPrep Kit (Qiagen). The target region was
sequenced with the T7 primer.
For procedure 2, white clones were suspended in 20 μl LB medium. A
GoTaq G2 Green PCR reaction was set up with 1 μl suspended colony as
template in a total volume of 40 μl. The PCR products were analyzed by
agarose gel electrophoresis. Bands of correct size were excised and the
DNA-containing gel pieces frozen at −20°C for at least 1 h. Subsequently,
the gel pieces were thawed, resulting in the release of the DNA from the gel
through its porous matrix. The samples were spun down and the maximum
volume of the DNA-containing flow-through was subject to sequencing
with the T7 primer.
For procedure 3, which we now perform as standard, a 5 μl GoTaq G2
Green reaction mix was set up as a master mix. White clones were picked
and briefly dipped into the 5 μl reaction mix. The PCR reaction was
performed according to the manufacturer’s instructions. Final PCR
products were treated with 10 U exonuclease I (Exo I, ThermoScientific)
and 1 U rAPid alkaline phosphatase (Roche Diagnostics) at 37°C for
20 min. The enzymes were then heat inactivated at 95°C for 20 min and the
samples sequenced with the T7 primer. This procedure allows simple
scaling-up.
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Deep-sequencing and computational sequence analysis
sgRNA target sites were amplified as described above and quality controlled
on a 2% agarose gel. PCR fragments were then processed by NXT-Dx
(Ghent, Belgium) for multiplexed Illumina MiSeq PE250 amplicon
sequencing.
MiSeq reads were aligned with bwa mem 0.7.12-r1039 (Li, 2013
preprint) to the zebrafish genome version danRer7 (Zv9). Reads were
separated by amplicon sequence after mapping by matching the mapped
endpoints of each pair with the genomic locations of the amplicons. Mapped
read endpoints were required to be within 5 bases of the expected locations.
Sanger sequences were extracted using sangerseqR (Hill et al., 2014) and
CrispRVariants (Lindsay et al., 2015 preprint) (see below), with base
recalling to resolve ambiguous bases, as we found this method to reduce
allele count in informal benchmarking of F1 samples (containing only two
alleles). Subsequently, the Sanger data were processed similarly to the
MiSeq data, except for the amplicon separation step.
We developed an R software package named CrispRVariants to perform
the variant counting and visualization (Lindsay et al., 2015 preprint).
Variants were counted within the region from 5 bp upstream of the sgRNA
to 5 bp downstream of the protospacer adjacent motif (PAM). As single
nucleotide variants (SNVs) near the PAM can prevent cutting, or can result
from repairing a cut, sequences without either an insertion or a deletion were
separated into those containing a SNV and those matching the reference.
SNVs were identified in the region 8 bases upstream to 6 bases downstream
of the cut site. For calculating mutation efficiency, we first identified SNVs
with a frequency of at least 20% in at least one sample. Less frequent SNVs
were considered non-variant sequences, i.e. only sequences with insertions
or deletions were counted as variants. By inspecting the CrispRVariants
allele summary plots, we further identified and removed three pre-existing
insertion variants located away from the cut sites from the efficiency
calculations: (1) gol_ccB_off0 1: 6:1I, (2) hand2_ccB_off0 1: -11:16I and
(3) hand2_ccA,hand2_ccB: 26:9I (between the two sgRNA locations).
When counting the number of (indel) variant alleles, a 1% frequency cutoff
was used for the MiSeq data to avoid inflating the allele counts by including
rare sequencing errors. No cutoff was used for the Sanger data. Variant
locations with respect to Zv9 annotated genes were determined using the R
Bioconductor package VariantAnnotation (Obenchain et al., 2014). When
variant locations differed between transcripts of a gene, the location most
likely to affect the protein sequence was used, with splice sites considered
more consequential than exonic sites.
Comparison with the sequencing data from Gagnon et al. (2014) was
performed with the original data kindly provided by the authors. All MiSeq
data have been deposited at ArrayExpress with accession E-MTAB-4143.
CrispRVariants is accessible and explained in detail in Lindsay et al. (2015
preprint).
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